SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-20-000062
Filing Date
2020-05-07
Accepted
2020-05-07 16:16:16
Documents
16
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20200507.htm   iXBRL 8-K 51098
2 EX-99.1 q12020financialresults.htm EX-99.1 134107
8 tricidalogoa031.jpg GRAPHIC 6561
  Complete submission text file 0001595585-20-000062.txt   355130

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20200507.xsd EX-101.SCH 2574
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20200507_cal.xml EX-101.CAL 720
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20200507_def.xml EX-101.DEF 1657
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20200507_lab.xml EX-101.LAB 25293
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20200507_pre.xml EX-101.PRE 13200
14 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20200507_htm.xml XML 11377
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 20856621
SIC: 2834 Pharmaceutical Preparations